Schizophrenia: elevation of dopamine D 4 -like sites, using [ 3 H]nemonapride and [ 125 I]epidepride

By Seeman P.   Hong-Chang G.   Van Tol H.H.M.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

Effect of clozapine and risperidone on 5-HT 2 and D 2 -dopamine receptor binding in the post-mortem human brain. An autoradiographic study

By Hall H.   Halldin C.   Nyberg S.   Farde L.   Sedvall G.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D 3 -receptor ligands

By Matzanke N.   Lowe W.   Perachon S.   Sokoloff P.   Schwartz J.-C.   Stark H.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 10, 1999-10 ,pp. : 791-798

Elsevier

Access to resources Recommend Favorite

Atypical antipsychotic-like effects of the dopamine D 3 receptor agonist, (+)-PD 128,907

By Witkin J.   Gasior M.   Acri J.   Beekman M.   Thurkauf A.   Yuan J.   DeBoer P.   Wikstrom H.   Dijkstra D.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

In vitro affinity of piribedil for dopamine D 3 receptor subtypes, an autoradiographic study

By Cagnotto A.   Parotti L.   Mennini T.  

European Journal of Pharmacology, Vol. 313, Iss. 1, 1996-10 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite